Daily Stock List
Cannabis Science, Inc. (CBIS)
Stock Analyzer reported today on Cannabis Science, Inc. (CBIS), Padded Cell Network, Penny Stock Rumble, Greenbackers, TheLightningPicks, Beacon Equity Research, Stock Preacher, InvestorSoup, Stock Roach, MicroStockProfit, Penny Stocks Finder did last week, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTCQB, Cannabis Science, Inc. is at the forefront of cannabinoid research and development for unmet medical needs. The Company works with leading experts in HIV drug development, medicinal characterization, and clinical research to develop, produce, and commercialize Phytocannabinoid-based pharmaceutical products. Cannabis Science™ has strong roots in - and an established relationship of trust with - the U.S. and Canadian medical cannabis patient communities. The Company is based in Colorado Springs, Colorado.
Cannabis Science's intention, at least in their first phase of existence, is to deal primarily in intellectual properties "patents on products and processes" leaving capital-intensive problems including regulatory compliance, mass production and marketing to the established pharmaceutical companies who license their patents. The Company is focusing on a relatively new and under-explored niche in the pharmaceutical market - whole-plant cannabinoid compounds derived from certified organic ingredients.
Broadly described, Cannabis Science's product is medical cannabis. This is a term which encompasses a wide array of products. This ranges from plants grown by patients for their own use to pharmaceutical products developed from one or more of the cannabinoid compounds found in the whole cannabis plant. Cannabinoids are a group of terpenophenolic compounds present in Cannabis (Cannabis sativa L).
This past June, Cannabis Science announced their new acquisition of the "Trimcare Brand" including their full medical clinic operations in Las Vegas, Nevada. Trimcare specializes in Supplements, Skin Care Products, Food, Weight Loss Programs, and Hormone Products. The Trimcare Brand currently has 30 Over-The-Counter (OTC) products on the market.
At present, Cannabis Science is working with CBR International to develop a Pre-IND Application to the FDA that focuses on the transdermal delivery of CS-TATI-1 topical cannabis-based preparations for the treatment of basal and squamous cell carcinomas. Recent presentations at AIDS 2012 and The International Conference on Antiviral Research have spurred federal research interest in the development of CS-TATI-1.
Recently, Cannabis Science announced the appointment of J. Thomas August, MD, Professor, Pharmacology and Molecular Sciences, and Oncology, The Johns Hopkins School of Medicine, to the Company’s Scientific Advisory Board. Dr. August’s distinguished career in clinical research directed at the molecular biology and protein structure of RNA viruses, and clinical exploration of human immunology has positioned him as a leading authority on human immune response mechanisms.
Cannabis Science, Inc. (CBIS), closed Monday's trading session at $0.0394, up 2.34%, on 1,768,949 volume with 122 trades. The average volume for the last 60 days is 1,806,934 and the stock's 52-week low/high is $0.0085/$0.2455.
Orbite Aluminae, Inc. (EORBF)
Today we are highlighting Orbite Aluminae, Inc. (EORBF), here at the QualityStocks Daily Newsletter.
Orbite Aluminae, Inc. is a leading provider of clean technology and a developer of alternative solutions for the alumina production industry. Today, Orbite Aluminae announced that they will start trading on the OTCQX International. Effective today, Monday, September 10, 2012, Orbite will trade on the OTCQX® under the symbol "EORBF." The Company formerly went by the name Exploration Orbite VSPA, Inc. They changed their name to Orbite Aluminae, Inc. in October 2011. Orbite Aluminae has their head office in Saint-Laurent, Québec.
The Company’s unique technologies for extracting metallurgical-grade alumina from aluminous clay are well positioned to replace a major portion of the higher-cost alumina Québec smelters import each year, and to set the stage for potential exports. Québec is the world’s third-largest producer of aluminum. Metallurgical-grade alumina is the normal feedstock for aluminum smelters.
Orbite Aluminae’s technologies enable environmentally-neutral extraction of smelter-grade alumina (SGA), high-purity alumina (HPA), and high-value elements, including rare earths and rare metals, from an array of sources such as aluminous clay and bauxite, without generating the toxic red mud residue that the traditional Bayer process produces. Orbite Aluminae owns ten different families of intellectual property rights (and patents pending) filed worldwide for the extraction of alumina at the highest standards of sustainability.
In addition, the Company also owns exclusive mining rights over 60,984 hectares. This includes the 6,665-hectare Grande-Vallee property, the site of an aluminous clay deposit in Quebec. An NI 43-101 compliant report dated May 30, 2012 identified more than one billion tonnes of aluminous clay in part of this deposit.
Currently, Orbite Aluminae is converting their 2,600 m2 pilot plant in Cap-Chat, Quebec, into a full-scale high-purity alumina production facility. They expect this plant to be fully operational in early 2013. They also anticipate the launch of construction of their first SGA plant towards the end of 2013. The Company plans to offer SGA and HPA products and to license their low processing cost technologies to well-qualified producers who want to reduce their environmental footprint. They recently entered into partnerships with the world's largest aluminum producer, UC Rusal.
Orbite Aluminae, Inc. (EORBF), closed Monday’s trading session at $2.5137, up 11.23%, on 31,170 volume with 59 trades. The average volume for the last 60 days is 20,487 and the stock's 52-week low/high is $1.26/$3.79.
Cream Minerals Ltd. (CMA.V)
Today we are reporting on Cream Minerals Ltd.(CMA.V), here at the QualityStocks Daily Newsletter.
Cream Minerals Ltd. is a precious metals exploration company with a portfolio of five solely owned highly prospective properties, four in Canada and one in Mexico. The Company’s objective is to acquire low risk high reward silver and gold properties and develop them to an advanced stage to maximize shareholder value. Cream Minerals has their headquarters in Vancouver, British Columbia. The Company lists on the TSX Venture Exchange, and on the OTCQB under the symbol “CRMXF.”
Cream Minerals’ current focus is the Nuevo Milenio Silver-Gold Project, Nayarit State, Mexico. The 100 percent owned Nuevo Milenio silver-gold project encompasses 2,560 Hectares (Ha). In addition, the Company has acquired an option to earn a 100 percent interest in the Wine and Wine 1 minerals claims, located approximately 60 kilometers southeast of Flin Flon, Manitoba. The Wine and Wine 1 claims cover an east west trending mafic intrusion (1,700 m X 700 m) that has known copper, nickel, platinum, palladium and gold mineralization spatially related to the intrusion and its contact with the surrounding country rocks.
Cream Minerals also has their Kaslo Silver Property in British Columbia. The 100 percent owned 4,000-hectare Kaslo Silver Property is located 12 kilometers west of the town of Kaslo. The Kaslo Silver Property encompasses nine former high-grade silver-lead-zinc mines located in southeastern British Columbia.
Additionally, the Company has their Goldsmith Gold Property in British Columbia. The Goldsmith Property is west of Poplar Creek on Highway 31, 66 kilometers north of Kaslo. The Goldsmith Property contains several historic, small, high-grade gold workings (Lucky Jack, Bullock, Swede, Goldsmith, Gold Park, and others) throughout a 3-kilometer long belt of altered volcanic and sedimentary host rocks.
At the end of July 2012, Cream Minerals announced the completion of the updated mineral resource estimate at their Nuevo Milenio Silver-Gold Project (Nuevo Milenio) in Nayarit State. In addition, they also announced that the Board of Directors initiated a review of the Company’s strategic alternatives intended to maximize shareholder value. A Special Committee of independent Directors was appointed.
The 2012 Independent Mineral Resource Estimate replaces in entirety the 2008 Inferred Mineral Resource Estimate previously disclosed by Cream Minerals. The Company advised that the 2008 Inferred Mineral Resource Estimate can no longer be relied upon.
Cream Minerals Ltd. (CMA.V), closed Monday at $0.095, up 18.75%, on 311,924 volume. The stock's 52-week low/high is $0.04/$0.30.
E-Waste Systems, Inc. (EWSI)
TooNiceStocks, ChartPoppers, Greenbackers, 1-2-3 Stock Alerts, The Stock Scout, Penny Stock Pros, PennyStockClub, StockMarketQuote.us, Penny Stocks VIP, and Penny Stock Circle reported earlier on E-Waste Systems, Inc. (EWSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Headquartered in London, England, E-Waste Systems, Inc. established to create a market-leading, integrated business in the emerging waste electrical and electronics equipment (WEEE) industry. The Company targets businesses facing regulatory or other mandates for handling e-waste. E-Waste’s plan is to acquire a select number of high-quality companies with strong management teams that have a shared commitment to helping customers achieve cost effective and environmentally responsible compliance with e-waste recycling and disposal requirements. The Company lists on the OTCQB.
E-Waste Systems will leverage and extend their acquisitions' established customer relationships by expanding the services offered to customers, applying best practices in professional management, and by investing in state-of-the-art recycling technology. The Company bases their categories of e-waste on the WEEE Directive categories; they operate a zero-landfill objective. E-Waste Systems has advanced state-of-the-art processes to achieve maximum extraction of materials to produce new manufacturing input.
Concerning E-Waste Recycling, the Company offers multi-national WEEE-Directive standards of recycling and secure asset recovery and end of life management services. These include management of a client’s returns, refurbishment of still useful items, re-use/resale, and complete recycling services. They recycle entire ranges of electronic waste such as from small domestic appliances to computer equipment, from televisions to medical equipment; from electronic toys to electronic tools. They operate with a zero-landfill objective and provide certificates of data destruction with access to visual evidence of the processing.
The Company has launched a new division of E-Waste Systems as a vital step in the execution of the fair-trade e-waste program. Under this program, end-of life electronics sourced in either the United States or Mexico can be processed by way of a highly compliant partner network of facilities with access to up to 500,000 square feet of space located primarily in Texas, California and northern Mexico.
E-Waste Systems, in the fourth quarter of 2011, completed the acquisition of Tech Disposal, Inc., and is now completely restructuring that operation. Tech Disposal is an electronic waste recycler and asset recovery specialist based in Columbus, Ohio. E-Waste Systems subsequently announced Letters Of Intent to acquire four end-of-life electronics companies; with operations located in the Southwest, Southeast, Central and Western regions of the U.S. They expect to announce another in the Northeast U.S.
E-Waste Systems, Inc. (EWSI), closed Monday’s session at $0.0195, up 30.00%, on 2,413,451 volume with 50 trades. The average volume for the last 60 days is 609,310 and the stock's 52-week low/high is $0.0095/$0.047.
Pegasi Energy Resources Corp. (PGSI)
AwesomePennyPicks reported earlier on Pegasi Energy Resources Corp. (PGSI), FeedBlitz did previously, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Listed on the OTCBB, Pegasi Energy Resources Corp. is an organic growth-oriented independent oil and gas exploration and production company. They focus on a repeatable, low geological risk, high potential project in the active East Texas oil and gas region. Their strategy is to establish a portfolio of drilling opportunities to exploit undeveloped reserves to grow production, as well as undertaking exploration to grow future reserves. Pegasi Energy Resources is based in Tyler, Texas.
Currently, they hold interests in properties located in Marion and Cass County, Texas, home to the giant Rodessa oil field. This field has produced approximately 2.3 trillion cubic feet of gas and 400 million barrels of oil. The field has historically been the domain of small independent operators and is not a legacy field for any major oil company. Pegasi's business strategy (designated the "Cornerstone Project" or "CP") is to identify and exploit resources in and adjacent to existing or indicated producing areas within the Rodessa field area.
The Company carries out their main exploration and production operations through their wholly owned subsidiary, Pegasi Operating, Inc. They conduct additional operations by way of another wholly owned subsidiary: TR Rodessa, Inc. TR Rodessa operates a 40-mile natural gas pipeline and gathering system. It is currently being used by Pegasi to transport their hydrocarbons to market. Excess capacity on this system is used to transport third-party hydrocarbons.
Last month, Pegasi Energy Resources provided investors with an update on the production of the Morse Unit #1-H, their first horizontal well, in Cass County, Texas, following 30 days of oil production.
An independent contractor reported a wellhead production rate of 288 bpd oil and 454 MCF gas at 3 AM August 3, 2012.
This spot production rate of 364 BOE (Barrels of Oil Equivalent) per day compares with an average for the previous 24hrs of 309 BOE. The well has consistently produced high quality, light, sweet oil of an API gravity greater than 40 degrees. Pegasi is currently designing an artificial lift system that the Company anticipates will enhance the well's production rate further.
Pegasi Energy Resources Corp. (PGSI), closed Monday’s trading session at $0.70, even for the day, on 22,500 volume with 5 trades. The average volume for the last 60 days is 49,308 and the stock's 52-week low/high is $0.38/$1.05.
Arsenal Energy, Inc. (AEI.TO)
AllPennyStocks reported previously on Arsenal Energy, Inc. (AEI.TO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Arsenal Energy, Inc. is an energy exploration and production company with corporate headquarters in Calgary, Alberta. The Company has producing properties in Canada and the U.S. Their core focus areas are Southeastern Alberta (medium gravity oil); North Dakota (Bakken), and the Columbia Deep Basin (Cardium, Wilrich). Arsenal Energy lists on the Toronto Stock Exchange.
For Development, in the Eastern Alberta Stable Base, the Company has an expanded waterflood at Provost. They also have a new waterflood at Princess. They have low decline rates – 8 percent base decline rate. In addition, they have high operating margins - $35/BOE. Concerning Bakken development in North Dakota, Arsenal Energy has multi year inventory in Bakken and Three Forks and low risk.
In June, Arsenal Energy updated North Dakota completions and Princess, Alberta planned drilling. At Stanley North Dakota, the Company, as operator, completed and tested the Anthony Robert two mile horizontal Bakken well. The well flowed at 978 bbls/d of oil during a 24 hour test period and was turned over to production. The offsetting Wade Morris horizontal Bakken well was successfully fracture stimulated but plugged off with sand during flow back. At Princess in Eastern Alberta, Arsenal contracted a drilling rig for two horizontal Glauconite wells. Arsenal has a 100 percent working interest in each well and has identified 16 possible follow up wells from 3D seismic.
In August, Arsenal Energy released their 2012 Q2 results. Production for the second quarter increased by 95 percent to 3,555 boe/d compared to Q2 2011. The increase resulted from new Bakken wells in North Dakota and from an acquisition that closed in November of 2011. The Company’s Q2 production mix was 73 percent oil and liquids and 27 percent natural gas.
Revenue increased by 45 percent to $18.4 million; cash flow increased by 52 percent to $6.5 million. Second quarter revenue and cash flow increases were not proportional to the production increase due to historically wide oil price differentials and low natural gas prices.
Arsenal Energy, Inc. (AEI.TO), closed Monday’s trading at $0.4750, up 5.56%, on 109,823. The stock's 52-week low/high is $0.40/$0.86.
Fuse Science, Inc. (DROP)
OurHotStockPicks and Xtremepicks reported today on Fuse Science, Inc. (DROP), and we choose to report on the Company as well, here at the QualityStocks Daily Newsletter.
Fuse Science, Inc. is a consumer products holding company that holds the rights to new, patent-pending technologies that they believe are poised to redefine how consumers receive energy, medicines, vitamins and minerals. The Company has discovered, through a combination of pending patents and trade secrets, that they can now encapsulate nutrients, actives and other molecules at a far greater concentration than at any time in history. The Company’s shares trade on the OTCQB. Fuse Science has their headquarters in Miami Lakes, Florida.
The Company believes that their Fuse Science innovations can deliver Energy, Nutrition, Medication, Skin Care and an endless number of other products with faster absorption, quicker results and better efficacy. The Company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can effectively encapsulate and charge many varying molecules to produce complete product formulations that can bypass the gastrointestinal tract and enter the blood stream directly. These are all in a concentrated "DROP" form that is applied under the tongue. The design of Fuse Science technology is to accelerate transference of medicines or nutrients relative to traditional pills and liquids and that can enhance how consumers receive these products.
The Company’s initial area of focus provides innovative energy and body replenishment products that combine cutting-edge body delivery technology with two proprietary formulas for powering professional and amateur athletes. Fuse Science utilizes their unique, bonding technology. Fuse Science developed an electrolyte and energy delivery system for consumers. The consumer simply places a few drops in the mouth to enjoy very fast effects.
ENERJEL™ is their first topical product that uses elements of their delivery system. The proprietary formulation helps fatigued muscles feel energized. ENERJEL™ is applied topically to deliver sustained relief and an energized feeling.
In late August, Fuse Science announced that the 2012 NHL Southeast Division champion Florida Panthers are now Powered By Fuse™. The partnership will include Powered By Fuse™ integration into the Florida Panthers organization, fan base, and the Saveology.com Iceplex – the official training facility of the Panthers and home to more than 750,000 hockey players, skaters and fans annually.
Fuse Science, Inc. (DROP), closed Monday’s trading session at $0.115, down 4.17%, on 824,824 volume with 89 trades. The average volume for the last 60 days is 1,164,762 and the stock's 52-week low/high is $0.0751/$1.25.
Bitzio, Inc. (BTZO)
AllPennyStocks reported today on Bitzio, Inc. (BTZO), SmallCapVoice, Investor News Source, Stock Twiter, HotStockProfits, Penny Dreamers, Greenbackers did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Bitzio, Inc. is a leading mobile media and app development company that lists on the OTCQB. The Company focuses on connecting fans of large entertainment and sports properties with the players, celebrities and teams they love. Bitzio licenses media rights of sports and entertainment properties that already have millions of existing fans. The Company subsequently leverages these rights to create mobile apps and web experiences for these existing fan bases. Founded in 2011, Bitzio has their corporate headquarters in San Francisco, California.
The Company offers premier quality apps for existing communities of fans. They leverage media rights to deliver relevant experiences; therefore this allows fans to deepen their engagement with their favorite clubs and star players. Bitzio collects powerful analytical information for targeted cross selling; this is enormously attractive to advertisers and sponsors. The Company’s objective is to be responsible for the download of one billion apps by 2014. Powering these apps is the Bitzio Engine. It captures valuable user data and drives increased user monetization.
On July 27, 2011, the Company acquired Bitzio Corp., a developer of mobile applications for smartphones, now operated as Bitzio Mobile Apps, Inc. On November 9, 2011, Bitzio acquired Thinking Drone, Inc., a developer of iPhone and Android apps under the "Free the Apps" brand. On January 10, 2012, they acquired DigiSpace Solutions, LLC, an online performance-based advertising company.
On May 23, 2012, Bitzio and Motion Pixel Corporation Holdings entered into a share purchase agreement whereby Bitzio acquired all of the issued and outstanding member's equity in exchange for 6,500,000 shares of the Company's common stock valued at $2,145,000. On June 4, 2012, Bitzio and ACT Smartware GmbH entered into a share purchase agreement whereby Bitzio acquired all of the issued and outstanding member's equity in exchange for 3,300,000 Series A Convertible Redeemable Preferred shares of the Company valued at $2,084,231.
Last week, Bitzio announced a licensing partnership with NFL Players, Inc., the licensing and marketing subsidiary of the NFLPA, to develop an innovative, player-based trivia application for IOS devices. The Football Trivia app will launch in mid-October. It will pit fan against fan as they answer trivia questions about a selected player in a competitive duel of football knowledge.
Bitzio, Inc. (BTZO), closed Monday’s trading session at $0.18, up 12.50%, on 18,250 volume with 7 trades. The average volume for the last 60 days is 14,407 and the stock's 52-week low/high is $0.123/$0.70.
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.75, up 12.90%, on 8,170 volume with 13 trades. The stock’s average daily volume over the past 60 days is 7,464, and its 52-week low/high is $1.50/$4.00.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
Duma Energy Receives Approval From Government of Namibia for Exploration License Issued for 5.3 Million-Acre Concession
Duma Energy Acquires Interest in 5.3 Million-Acre African Concession
Duma Energy Enters Final Stage of Negotiations for African Concession
MusclePharm Corp. (MSLP)
The QualityStocks Daily Newsletter would like to spotlight MusclePharm Corp. (MSLP). Today, MusclePharm Corp. closed trading at $0.01, up 1.00%, on 3,832,510 volume with 49 trades. The stock’s average daily volume over the past 60 days is 1,588,001, and its 52-week low/high is $0.0055/$0.0375.
MusclePharm Corp. (MSLP) is focused on providing a full line of Informed Choice-approved nutritional supplements that not use any substances banned in the sports industry. Now sold in more than 120 countries and available in over 10,000 U.S. retail outlets, the company's products address all categories of an active lifestyle, including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen.
Current CEO Brad Pyatt founded the company to develop a superior line of nutritional supplements that would help fellow athletes improve their performance in a way that existing supplements did not. Even as the company has grown, its mission has remained the same: to improve its customers' lives, increase their ability to excel, use cutting-edge science to develop the best nutritional supplements on the market, and provide a safe option for athletes.
MusclePharm's products were developed through exhaustive research at the MusclePharm Sports Science Center Research Institute. New products are created through a six-stage research protocol that involves the expertise of top nutritional scientists. Before launching a product, the company conducts field testing using a pool of over one hundred elite professional athletes from various professional sports leagues, including the National Football League, Mixed Martial Arts, and Major League Baseball.
Over the last few years, the consumption of sports nutrition products has shifted to mainstream consumers who have become the key drivers of growth within the industry. Teenagers and college students, women, and even older individuals are now using these products to help them live a more active and healthier lifestyle. With a full line of supplements and an extensive distribution network, MusclePharm is well positioned to capitalize on the growing demand. Disclaimer
MusclePharm Corp. Company Blog
MusclePharm Corp. News:
United States Sports Academy Researchers Present Clinical Trial Results For MusclePharms' Assault™ Pre-Workout
MusclePharm Announces Board Changes, Expansion
MusclePharm Nominated For 18 Bodybuilding.com Supplement Awards
Skinny Nutritional Corp. (SKNY)
The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.01, even with yesterday's close, on 446,800 volume with 7 trades. The stock’s average daily volume over the past 60 days is 2,005,915, and its 52-week low/high is $0.0042/$0.0449.
Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.
The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.
The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.
Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer
Skinny Nutritional Corp. Blog
Skinny Nutritional Corp. News:
Skinny Nutritional Corp. to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+
A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration
Skinny Nutritional Corp. Enters Into $15M Financing, Positions Company to Grow Skinny Brand Portfolio Nationally
Teletouch Communications, Inc. (TLLE)
The QualityStocks Daily Newsletter would like to spotlight Teletouch Communications, Inc. (TLLE). Today, Teletouch Communications, Inc. closed trading at $0.46, off by 8.91%, on 14,472 volume with 4 trades. The stock’s average daily volume over the past 60 days is 16,494, and its 52-week low/high is $0.253/$0.89.
Teletouch Communications, Inc. (TLLE) offers a comprehensive suite of wireless telecommunications solutions, including cellular, GPS-telemetry, and wireless messaging. Founded in 1964, the company provides its products and services to consumers, businesses, and government agencies, operating a chain of 11 retail and authorized agent stores, in conjunction with its direct sales force, call center operations, and various retail eCommerce websites.
Through its wholly owned subsidiary, Progressive Concepts, Teletouch operates a national distribution business, PCI Wholesale, primarily serving Tier-1 (AT&T, T-Mobile, Verizon, Sprint) cellular carrier agents, Tier-2, Tier-3, and rural carriers, as well as auto dealers and smaller consumer electronics retailers. The subsidiary's international sales coverage includes Canada, Mexico, Brazil, Singapore, and China.
The company is currently focusing on growing its core wholesale distribution business. The business plan being executed includes selling non-core corporate assets and reviewing potential acquisition opportunities. Operators and retailers of all sizes are seeking new sources of revenue at lower costs, creating a large opportunity to provide great products and value-added distribution capabilities at competitive prices.
Teletouch's management team has extensive experience in financing, acquiring, and operating retail, wireless and other related companies. Robert McMurrey, Chairman and CEO, guided Teletouch's original external expansion with the completion of over 15 acquisitions to date. Today, the company supports over 60,000 wireless customers, leveraging its long-standing relationships and global presence to drive future earnings growth. Disclaimer
Teletouch Communications, Inc. Blog
Teletouch Communications, Inc. News:
Teletouch Reports Fiscal Year 2012 Results
Teletouch 2012 Fiscal Year Ending May 31st Report Scheduled for August 29, 2012
Teletouch Sells Legacy Two-Way Radio Division to DFW Communications for $1.5 Million
Skinny Nutritional now offers Skinny Water pH+, a high alkaline and electrolyte water, that gives consumers a healthy alternative to acidic beverages such as soft drinks. Michael Salaman, CEO of SKNY, stated, “The body is in an alkaline state when it reaches 7 on a pH scale of 1 to 10. Our bodies tend to be more acidic due to the acidic nature of the typical American diet that consists of soft drinks and processed foods. Skinny Water pH+ targets a pH level of 8 to 9 to help keep the body in balance.” The idea for Skinny Water pH+ came from the alkaline diet followed by celebrities and suggested by medical personnel.
Alkaline diets rich in magnesium, zinc, and potassium, which are found in fruits and vegetables, are believed to help a person’s physical well-being in many ways. Higher energy levels, clearer skin, faster metabolism, a clear mind, and greater immunity are just some of the benefits of an alkaline diet. An alkaline body may also experience greater weight loss. The human body is mostly water, so consuming Skinny Water pH+ can help balance the body’s water make-up.
Skinny Water pH+ promotes the idea that the human body should maintain an optimum balance of acidity and alkalinity. In contrast to SKNY’s flavored waters, Skinny Water pH+ is crystal clear, with a pure and crisp taste that features a boost of electrolytes for replenishment and added energy. It is the ultimate beverage for pure hydration plus the electrolytes and alkalinity you need to maintain your body’s best balance. In simplest terms, Skinny Water pH+ is the drink of choice for a positive, health-conscious lifestyle.
SKNY also continues its market penetration in the mid-Atlantic region. SKNY and the Great Atlantic & Pacific Tea Company, doing business as A&P, have signed an agreement putting SKNY products in 275 store locations. These locations will include stores operating under the Pathmark, Superfresh, Waldbaum’s and A&P names. Joseph Gisondi, VP of National Retail Sales, stated, “Skinny Nutritional Corp. and A&P look forward to building and cultivating the Skinny Water brand through various advertising mediums which will include circular/ad sales, displays, sampling events and joint promotions.” Nationwide, Skinny Water is available in over 14,275 retail locations.
For additional information, visit the company’s websites at www.SkinnyWater.com
Teletouch Communications, Texas-based cellular services provider and growing consumer electronics distributor, recently held a shareholder conference call highlighting previously released financial results for the 4th fiscal quarter and fiscal year ending June 7, 2012, along with a number of operational issues. The call included Robert McMurrey (Chairman and CEO of Teletouch), Thomas “Kip” Hyde, Jr. (President & COO, and CEO of primary operating company PCI Hawk Electronics), Douglas Sloan (CFO), and Mike Dickens (Sr. VP of Operations).
The core of the presentation dealt with the company’s move back to profitability and growth, coming out of a particularly challenging year involving unpredictable events.
In spite of these unavoidable pressures, Teletech ended up generating reported net income of $6.3 million and $.08 fully diluted earnings per share for the year, the strongest earnings the company has seen in a decade. Fourth quarter net income was $161,000. The company also settled a two year long litigation with AT&T, and expects to close on new financing, all of which allows Teletouch to focus on their core strategy of growing their distribution operations. The company’s goal remains the transitioning of Teletouch into a market leader in the distribution business.
Shortly after the end of the fiscal year, Teletouch announced the signing of their first direct handset manufacturing distribution agreement with TCT Mobile, one of the largest consumer manufacturing companies in the world and the maker of the Alcatel OneTouch brand of cellular handsets, as well as a dozen other cellular equipment and accessory distribution agreements to support their wholesale business growth strategy.
During the call’s question and answer period, the anticipated effect of the TCT agreement on Teletouch revenues was discussed. The company believes that the new relationship should clearly generate several million dollars top line and then the related margins bottom line. It was pointed out that the initial order was just signed, and it takes about 45 days for product to be on the ground. Kip Hyde said of the agreement: “It’s our first handset deal. We’re pretty excited about it. We do have another handset deal that we will be announcing shortly…, and the combination of these will represent a real foundation to growth over the next 12 months.”
Another question arose regarding the recent Samsung-Apple software litigation, and whether there was any software on the incoming Alcatel handsets that might be negatively impacted by the jury decision in the case. The response was that Teletouch has not been given any indication by the manufacturer that they’re in violation of any of the patents that were in dispute in the Samsung-Apple litigation. To the extent that there is, the assumption is that they would modify their operating system accordingly, but that there is no indication that any ordered product would be impacted.
The complete earnings call is available at the Teletouch website at http://www.teletouch.com/EarningsCalls.asp
For more information on Teletouch Communications, Inc., visit www.teletouch.com
Loans4Less.com is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company’s expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulted on an obligation or been involved in any litigation, the company is poised for rapid growth in today’s low interest rate environment with its industry leading reputation and well established relationships with respected lenders.
For additional information, visit the company’s website at www.Loans4Less.com
TNI BioTech aims for world leadership in the area of immunology. It plans to fight infectious diseases by using Methionine Enkephalin (MENK), a human hormone produced naturally by the human immune system. It is believed that MENK is toxic to tumor cells but does not hurt the human body. TNIB’s most advanced clinical programs involve immunotherapy that works by isolating a patient’s lymphocytes and then incubating them together with an enriching external incubation system. After incubation, the patient’s lymphocytes are reinfused back into the patient where they combat and destroy tumor cells.
Although TNIB considers any condition that results in altered-immune response a target for investigation, the company will most likely focus its efforts on using MENK in the treatment of 5 major types of illnesses: 1) Autoimmune states such as rheumatoid arthritis and multiple sclerosis; 2) As an adjunct to antibiotics in the treatment of infectious diseases; 3) In cancer patients undergoing chemotherapy, radiation treatments, or surgery; 4) Patients with AIDS, in combination with retroviral drug therapy; and 5) In wound healing or herpes viral infections.
To further its goal of prominence in the field of immunology, the company recently acquired certain technology developed by Dr. Bernard Bihari, a well-known AIDS researcher. The portfolio portfolio contains six patents and applications related to:
• Cancer of the prostate, lymphoproliferative syndrome, including such diseases as malignant lymphoma, chronic lymphocytic leukaemia, Hodgkin’s lymphoma, and non-Hodgkin’s lymphoma;
• Infectious diseases such as chronic herpes virus infections, including chronic genital herpes caused by the herpes simplex virus, Type 2, chronic infections due to the Epstein-Barr virus, and chronic inflammatory conditions including chronic fatigue syndrome; and
• A treatment method for humans infected with HTLV-III (AIDS) virus, including patients clinically diagnosed as suffering from AIDS and those suffering from AIDS-related complex (ARC).
Dr. Bernard Bihari was the discoverer of the clinical effects of Low Dose Naltrexone (LDN) in humans. In his groundbreaking clinical trial of patients with HIV/AIDS at Downstate Medical Center in 1985-86, Dr. Bihari discovered the significant effectiveness of LDN in protecting the battered immune systems of those who were infected. Equipped with the clinical trial knowledge, he entered private practice in an attempt to counter the then untreatable disease by using LDN – and did so in some cases dramatically. TNIB intends to continue Dr. Bihari’s work on the use of LDN by conducting Phase III trials.
Asked for comment on the purchase of Dr. Bihari’s technology, Dr. Nicholas Plotnikoff, Chairman of TNI BioTech, Inc., said, “I worked with Dr. Bernard Bihari for many years and I believe acquiring all of the technology of Dr. Bihari will allow the company, we hope, to move forward to phase III clinical trials in both the United States and Africa within the next 12 months. In our opinion, LDN holds great promise for the millions of people worldwide with autoimmune diseases or central nervous system disorders or who face a deadly cancer. It could prove to be the first low-cost, easy to administer, and side-effect-free therapy for Cancer, HIV/AIDS, MS and Crohn’s disease.”
Another major step forward for the company was Dr. Ronald Herberman joining the company as Senior Vice President of Research and Development and Chief Medical Officer. Dr. Herberman’s responsibilities include leading the company’s global development, clinical research, and medical initiatives.
Dr. Herberman is widely recognized as a top researcher in the field of immunology. He has received many awards, including the Lifetime Science Award from the Institute for Advanced Studies in Immunology and Aging. During the period of 1981 to 1990, Dr. Herberman was recognized as one of the 100 most-cited research authors in the immunology area.
Dr. Nicholas Plotnikoff, TNI BioTech, Inc. Chairman, noted that the company’s hiring of Dr. Herberman reflects TNI BioTech’s highest priority: to become a world-class leader in groundbreaking therapeutics for patients who are afflicted with cancer, autoimmune, and infectious disease, including HIV/AIDS.
“In order to successfully become a world-class leader,” stated Dr. Plotnikoff, “we need significant expertise in clinical, regulatory and leadership development, along with a deep knowledge of immunology and Dr. Herberman brings demonstrated strengths in these areas having made major discoveries in his field and has fostered the application of this information to novel approaches to cancer therapy, diagnosis and prevention during his time as a leader at the National Cancer Institute and Founding Director of the University of Pittsburgh Cancer Institute.”
Dr. Plotnikoff added, “During his career, Dr. Herberman has been recognized as a leader in the field of immunology. The phenomenon of natural killer (NK) cell-mediated cytotoxicity against tumors was first discovered in Dr. Herberman’s laboratory at the National Cancer Institute in the early 1970s. In addition to his pioneering investigation of NK cells, Dr. Herberman has played a leading role in multiple areas of tumor immunology. TNI BioTech therapies and treatments draw upon the theory that medicine can enlist the body’s own immune system to combat cancer and autoimmune diseases that are Dr. Herberman’s specialty. His experience and strategic perspective precisely meet TNI BioTech’s needs today.”
Dr. Herberman commented: “I am very excited to assume a leadership position in TNI Biotech Inc. I have had the privilege to know Dr. Plotnikoff for about 30 years and I have been very impressed with his pioneering studies of the effects of opioid peptides on the immune system. I am convinced that TNI Biotech’s drugs have much potential for the treatment of not only cancer, but also a range of other diseases including multiple sclerosis, HIV/AIDS, and Crohn’s Disease. I intend to rapidly build on a pre-existing foundation of clinical research with low dose naltrexone and MENK, and develop innovative approaches to use them to stimulate the immune system to make an impact on these and other chronic diseases.”
In addition to his other duties, Dr. Herberman will be a member of the company’s executive leadership team. He will report to Dr. Eugene Youkilis, President and the Board of Directors. As the company’s Chief Medical Officer, Dr. Herberman will employee his extensive experience in all phases of drug development and drug portfolio management — including acquisition of new assets and relationships with regulators and government agencies. Dr. Herberman will also retain specific accountabilities relating to patient safety.
To learn more about the company and its immunotherapy technologies, visit www.tnibiotech.com
Today's Top 3
The QualityStocks Public Company Sponsor News